Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cardiosense
Chicago, Illinois, United Statescardiosense.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Results from the SEISMIC-HF I Study demonstrated that Cardiosense’s machine learning model can non-invasively assess cardiac filling pressure. These results were presented as late-breaking science at the American Heart Association’s Scientific Sessions in December 2024.
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceDigital biomarker platformArtificial intelligence (AI)Software analytics platform
- Industry
- Physiological Monitoring
02
Partnerships
Broadview VenturesHatteras Venture PartnersOSF VenturesUnityPoint Health VenturesLaerdal Million Lives Fund
Beyond the preview
Go deeper on Cardiosense.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cardiosense.